New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study finds heightened risk of cardiovascular disease among cancer survivors

Study finds heightened risk of cardiovascular disease among cancer survivors

Cancer survivors may be at long-term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk factors, suggest the findings of a large UK Biobank study, publis
World medicine November 23,2023
Study finds heightened risk of cardiovascular disease among cancer survivors

Study finds heightened risk of cardiovascular disease among cancer survivors

Cancer survivors may be at long-term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk factors, suggest the findings of a large UK Biobank study, publis
World medicine November 23,2023
Four important signs that signal increased risk of early-onset colorectal cancer identified

Four important signs that signal increased risk of early-onset colorectal cancer identified

Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. These red flags ma
World medicine November 23,2023
Four important signs that signal increased risk of early-onset colorectal cancer identified

Four important signs that signal increased risk of early-onset colorectal cancer identified

Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. These red flags ma
World medicine November 23,2023
Taletrectinib Under NMPA Review in China for Advanced or Metastatic ROS1+ NSCLC

Taletrectinib Under NMPA Review in China for Advanced or Metastatic ROS1+ NSCLC

November 22, 2023Courtney FlahertyThe Center for Drug Evaluation of China’s National Medical Products Administration has accepted the new drug application seeking the approval of the next-generation R
World medicine November 23,2023
Taletrectinib Under NMPA Review in China for Advanced or Metastatic ROS1+ NSCLC

Taletrectinib Under NMPA Review in China for Advanced or Metastatic ROS1+ NSCLC

November 22, 2023Courtney FlahertyThe Center for Drug Evaluation of China’s National Medical Products Administration has accepted the new drug application seeking the approval of the next-generation R
World medicine November 23,2023
HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

A technique that delivers high doses of heated chemotherapy directly to the abdominal cavity is a promising treatment for certain patients with Stage IV cancer. Hyperthermic intraperitoneal chemothera
World medicine November 23,2023
HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

A technique that delivers high doses of heated chemotherapy directly to the abdominal cavity is a promising treatment for certain patients with Stage IV cancer. Hyperthermic intraperitoneal chemothera
World medicine November 23,2023
Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

August 24, 2023Kristi RosaSovleplenib provided a statistically significant and clinically meaningful increase in durable response rate over placebo in adult patients with primary immune thrombocytopen
World medicine November 23,2023
Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

August 24, 2023Kristi RosaSovleplenib provided a statistically significant and clinically meaningful increase in durable response rate over placebo in adult patients with primary immune thrombocytopen
World medicine November 23,2023
Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.In laborat
World medicine November 23,2023
Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.In laborat
World medicine November 23,2023
SLS009 Plus Venetoclax/Azacitidine Displays Activity, Tolerability in Relapsed/Refractory AML

SLS009 Plus Venetoclax/Azacitidine Displays Activity, Tolerability in Relapsed/Refractory AML

October 17, 2023Chris RyanThe addition of SLS009 to the combination of venetoclax and azacitidine produced anti-leukemic effects and was safe in patients with relapsed/refractory acute myeloid leukemi
World medicine November 23,2023
SLS009 Plus Venetoclax/Azacitidine Displays Activity, Tolerability in Relapsed/Refractory AML

SLS009 Plus Venetoclax/Azacitidine Displays Activity, Tolerability in Relapsed/Refractory AML

October 17, 2023Chris RyanThe addition of SLS009 to the combination of venetoclax and azacitidine produced anti-leukemic effects and was safe in patients with relapsed/refractory acute myeloid leukemi
World medicine November 23,2023
Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

Aggressive periodontitis is a severe type of gum infection that causes the destruction of ligament and bone and can lead to tooth loss in otherwise healthy individuals. Traditional treatment typically
World medicine November 23,2023
Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

Aggressive periodontitis is a severe type of gum infection that causes the destruction of ligament and bone and can lead to tooth loss in otherwise healthy individuals. Traditional treatment typically
World medicine November 23,2023
SCO-101 Plus FOLFIRI Provides Survival Benefit in Metastatic Colorectal Cancer

SCO-101 Plus FOLFIRI Provides Survival Benefit in Metastatic Colorectal Cancer

November 22, 2023Kristi RosaSCO-101 in combination with leucovorin, fluorouracil, and irinotecan (FOLFIRI) provided a clinically meaningful overall survival benefit in heavily pretreated patients with
World medicine November 23,2023
SCO-101 Plus FOLFIRI Provides Survival Benefit in Metastatic Colorectal Cancer

SCO-101 Plus FOLFIRI Provides Survival Benefit in Metastatic Colorectal Cancer

November 22, 2023Kristi RosaSCO-101 in combination with leucovorin, fluorouracil, and irinotecan (FOLFIRI) provided a clinically meaningful overall survival benefit in heavily pretreated patients with
World medicine November 23,2023
Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Doctors have long stressed the importance of maintaining a healthy weight for improving overall health, but a large new study also suggests it could also reduce future gastrointestinal cancer (GI) ris
World medicine November 23,2023
Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Doctors have long stressed the importance of maintaining a healthy weight for improving overall health, but a large new study also suggests it could also reduce future gastrointestinal cancer (GI) ris
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com